Jaguar Health Inc (JAGX)
0.259
-0.03
(-9.66%)
USD |
NASDAQ |
May 17, 16:00
0.127
-0.13
(-50.97%)
After-Hours: 20:00
Jaguar Health SG&A Expense (Quarterly): 5.824M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.824M |
December 31, 2023 | 5.336M |
September 30, 2023 | 5.005M |
June 30, 2023 | 6.01M |
March 31, 2023 | 6.697M |
December 31, 2022 | 4.74M |
September 30, 2022 | 6.493M |
June 30, 2022 | 6.493M |
March 31, 2022 | 8.979M |
December 31, 2021 | 6.951M |
September 30, 2021 | 6.23M |
June 30, 2021 | 7.259M |
March 31, 2021 | 5.548M |
December 31, 2020 | 5.05M |
September 30, 2020 | 5.842M |
June 30, 2020 | 5.486M |
March 31, 2020 | 4.618M |
December 31, 2019 | 5.185M |
September 30, 2019 | 4.805M |
June 30, 2019 | 5.37M |
March 31, 2019 | 5.079M |
Date | Value |
---|---|
December 31, 2018 | 6.228M |
September 30, 2018 | 5.420M |
June 30, 2018 | 5.75M |
March 31, 2018 | 4.711M |
December 31, 2017 | 4.875M |
September 30, 2017 | 3.734M |
June 30, 2017 | 2.295M |
March 31, 2017 | 3.426M |
December 31, 2016 | 1.794M |
September 30, 2016 | 1.252M |
June 30, 2016 | 1.470M |
March 31, 2016 | 1.953M |
December 31, 2015 | 1.801M |
September 30, 2015 | 1.556M |
June 30, 2015 | 1.463M |
March 31, 2015 | 1.284M |
December 31, 2014 | 0.8993M |
September 30, 2014 | 1.456M |
June 30, 2014 | 1.245M |
March 31, 2014 | 0.495M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.618M
Minimum
Mar 2020
8.979M
Maximum
Mar 2022
5.896M
Average
5.686M
Median
SG&A Expense (Quarterly) Benchmarks
BioSig Technologies Inc | 4.91M |
BioVie Inc | 2.254M |
Entero Therapeutics Inc | 2.786M |
Genprex Inc | 2.270M |
Adial Pharmaceuticals Inc | 1.519M |